Shanghai Pharmaceuticals Holding Co (HKSE:02607) Construction In Progress : HK$2,470 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Construction In Progress?

Shanghai Pharmaceuticals Holding Co's quarterly construction in progress declined from Sep. 2024 (HK$4,312 Mil) to Dec. 2024 (HK$2,294 Mil) but then increased from Dec. 2024 (HK$2,294 Mil) to Mar. 2025 (HK$2,470 Mil).

Shanghai Pharmaceuticals Holding Co's annual construction in progress increased from Dec. 2022 (HK$3,102 Mil) to Dec. 2023 (HK$3,904 Mil) but then declined from Dec. 2023 (HK$3,904 Mil) to Dec. 2024 (HK$2,294 Mil).

Shanghai Pharmaceuticals Holding Co Construction In Progress Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Construction In Progress Chart

Shanghai Pharmaceuticals Holding Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Construction In Progress

Get a 7-Day Free Trial

2,059.34

3,568.26

3,101.52

3,904.39

2,294.06

Shanghai Pharmaceuticals Holding Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Construction In Progress	Get a 7-Day Free Trial															4,566.50	4,700.05	4,312.30	2,294.06	2,470.46

Shanghai Pharmaceuticals Holding Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Shanghai Pharmaceuticals Holding Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (HKSE:02607) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

SHPMY:USA S1R:Germany 601607:China

Address

No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020

Website

https://www.sphchina.com

Shanghai Pharmaceuticals is the second-largest medical distributor in China by revenue. It is vertically integrated and provides healthcare services in research and development, manufacturing, distribution, and retail. As of 2024, medical distribution is the largest segment, accounting for 91.3% of total revenue. It also has coverage of 31 provinces and cities nationwide.

Executives

Shanghai Industrial Investment (holdings) Company Limited	2201 Interest of corporation controlled by you
Siic International Investment Company Limited	2101 Beneficial owner
New China Asset Management Co., Ltd.	2102 Investment manager
New China Life Insurance Company Ltd.	2101 Beneficial owner
Blackrock, Inc.	2201 Interest of corporation controlled by you
Citigroup Inc.	2201 Interest of corporation controlled by you
Lsv Asset Management	2102 Investment manager

Shanghai Pharmaceuticals Holding Co Headlines

No Headlines